Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
J Am Coll Surg18 Jan 2024

Molecular profiling improves overall survival in patients with intrahepatic cholangiocarcinoma

In a comprehensive multidisciplinary clinic, molecular profiling of intrahepatic cholangiocarcinoma (ICC) identified actionable molecular alterations in 45% of patients, including mutations and amplifications. Among 120 patients with molecular profiling, the detection of these alterations significantly improved mean overall survival (OS) by 10.5 months. Additionally, in…

World J Gastroenterol18 Jan 2024

Impact of Guideline Adherence on the Prognosis of Stage B Hepatocellular Carcinoma

South Korean patients with Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC) showed significant variations in adherence to treatment guidelines over the study period of 2008-2016. Adherence to guidelines, particularly those recommended by the European Association for the Study of the Liver (EASL)…

Hepatobiliary Pancreat Dis Int18 Jan 2024

Study Finds No Association Between Perioperative Hypothermia and Surgical Site Infections in Liver Resection Patients

Perioperative hypothermia is not significantly correlated with surgical site infections (SSI) in patients undergoing liver resection, according to a retrospective cohort study. Researchers analyzed data from 4,000 patients and found that among those with hypothermia, 6.8% developed SSI. However, after propensity score matching, there were…

HPB & Spleen17 Jan 2024

Non-autologous reinforcement reduces postoperative pancreatic fistula after distal pancreatectomy: Meta-analysis of randomized clinical trials

Non-autologous reinforcement of the pancreatic stump following distal pancreatectomy significantly reduces the rate of postoperative pancreatic fistula (POPF), according to a meta-analysis of nine randomized clinical trials. The pooled analysis found a lower rate of POPF in the non-autologous reinforcement group compared to the non-reinforcement…

HPB & Spleen16 Jan 2024

Advances in the Management of Pancreatic Cancer: Recent Developments and Future Strategies

Despite improvements in survival over the years, pancreatic cancer continues to have poor outcomes compared to other malignancies. Multimodal treatment approaches involving chemotherapy, surgery, and radiotherapy have been studied extensively. Emphasis is now placed on selecting appropriate treatments based on local extension into major vessels.…

Ann Surg Oncol16 Jan 2024

Perioperative Lymphopenia Increases Risk of Recurrence and Impairs Survival After Hepatectomy for Hepatocellular Carcinoma

A new study investigated the prognostic value of perioperative lymphopenia on short- and long-term outcomes in patients undergoing resection of hepatocellular carcinoma (HCC). Researchers found that perioperative lymphopenia, particularly severe lymphopenia on postoperative day 5, was associated with worse 5-year overall survival and disease-free survival.…

Ann Surg14 Jan 2024

Ondansetron Demonstrates Efficacy in Treating Low Anterior Resection Syndrome (LARS)

Ondansetron, a serotonin receptor antagonist, shows promise as a safe and effective treatment for patients with Low Anterior Resection Syndrome (LARS). In a randomized study, patients who received ondansetron experienced a significant decrease in LARS severity and improvement in symptom scores compared to those who…